Refine
Has Fulltext
- yes (232)
Is part of the Bibliography
- yes (232)
Year of publication
Document Type
- Journal article (215)
- Conference Proceeding (11)
- Doctoral Thesis (4)
- Other (2)
Language
- English (232) (remove)
Keywords
- Chirurgie (26)
- Medizin (9)
- inflammation (9)
- Immunbiologie (8)
- colorectal cancer (8)
- obesity (8)
- cytokines (6)
- Immunobiologie (4)
- Roux-en-Y gastric bypass surgery (4)
- bariatric surgery (4)
- inflammatory bowel disease (4)
- Ureaplasma parvum (3)
- anastomotic leakage (3)
- chemotherapy (3)
- evidence-based medicine (3)
- guidelines (3)
- incisional hernia (3)
- indication for surgery (3)
- intestinal epithelial barrier (3)
- laparoscopic ventral hernia repair (3)
- liraglutide (3)
- open abdomen (3)
- perioperative management (3)
- sepsis (3)
- 5-Fluorouracil (2)
- Aspergillus (2)
- COVID-19 (2)
- CRC (2)
- Caco2 cells (2)
- Cancer (2)
- Crohn's disease (2)
- DNA damage (2)
- Fn14 (2)
- Germany (2)
- Krebs (2)
- Krebs <Medizin> (2)
- Langerhans-Inseln (2)
- MYC (2)
- NAFLD (2)
- NFκB (2)
- Rectal cancer (2)
- SARS-CoV-2 (2)
- Surgery (2)
- TWEAK (2)
- Transplantation (2)
- Ureaplasma urealyticum (2)
- adaptive immunity (2)
- adrenocortical carcinoma (2)
- agonistic antibodies (2)
- animal model (2)
- anticoagulation (2)
- antimicrobial stewardship (2)
- atrial fibrillation (2)
- biomarker (2)
- bridging (2)
- cancer (2)
- case report (2)
- cell death (2)
- colon cancer (2)
- complication (2)
- dendritic cells (2)
- desmosome (2)
- endoluminal (2)
- enzyme activation (2)
- enzyme inhibitors (2)
- extracorporeal membrane oxygenation (2)
- gastric bypass (2)
- gastric cancer (2)
- giant ventral hernia (2)
- gut barrier (2)
- ileocecal resection (2)
- immunoassay (2)
- ischemia (2)
- islets of Langerhans (2)
- laparostomy (2)
- malignant melanoma (2)
- meta-analysis (2)
- metabolism (2)
- metastasis (2)
- microbial spectrum (2)
- mortality (2)
- negative pressure (2)
- oxaliplatin (2)
- pancreatic cancer (2)
- parastomal hernia (2)
- pediatric (2)
- peptide tyrosine tyrosine (PYY) (2)
- peritoneal carcinomatosis (2)
- phosphodiesterase (2)
- postoperative bleeding (2)
- preterm infants (2)
- primary ventral hernia (2)
- rat (2)
- rectum (2)
- skin (2)
- surgery (2)
- surgical therapy (2)
- swine (2)
- synthetic mesh (2)
- therapy (2)
- thromboembolism (2)
- translational research (2)
- transplantation (2)
- treatment (2)
- umbilical hernia (2)
- vacuum conditioning (2)
- vacuum-assisted closure (2)
- ventral hernia (2)
- 15-Deoxyspergualin (1)
- 1st-line treatment (1)
- 5-fluorouracil (1)
- 6-percent hydroxyethyl starch (1)
- AAA (1)
- ALCL (1)
- Activation (1)
- Adrenocortical Carcinoma (1)
- Allergie (1)
- Allopeptidb (1)
- Allotransplantatabstossung (1)
- Apoptosis (1)
- Attentional performance (1)
- Autologous (1)
- BM (1)
- Barrett-Ösophagus (1)
- Bauchspeicheldrüsenkrebs (1)
- Beta-catenin (1)
- Blood–brain barrier (1)
- Brain μ-opioid receptors (1)
- C-MYC (1)
- CA19-9 (1)
- CASP (1)
- CCR7 (1)
- CD62L (1)
- CD8+ T cells (1)
- CIP2A (1)
- CNS integrity (1)
- COVID-19 pandemic (1)
- CT angiography (1)
- CX3CL1 (1)
- CX5461 (1)
- CXCL13 (1)
- Cancer immunotherapy (1)
- Carcinoma cells (1)
- Carcinomatosis (1)
- Central venous access (1)
- Central venous-pressure (1)
- ChIPseq (1)
- Chemotherapeutic resistance (1)
- Class II antigen blockade (1)
- Claudin2 (1)
- Cognitive (1)
- Coronary artery bypass graft (1)
- Coronavirus Disease 2019 (1)
- Critically-ill patients (1)
- Crohn’s Disease (1)
- Crohn’s disease (1)
- Cryolesion (1)
- Cushing (1)
- DNA repair (1)
- Danish hernia database (1)
- Diabetes (1)
- Dickdarmkrebs (1)
- Dsg2 (1)
- Dünndarm (1)
- EDS (1)
- EHS classification (1)
- ERK (1)
- Ehlers-Danlos syndrome (1)
- Elective cesarean-section (1)
- Electrical impedance tomography (1)
- EndoVAC and small bowel (1)
- Epstein-Barr virus (1)
- Experimental brain trauma (1)
- Expression (1)
- Extra-anatomical (1)
- FWGE (1)
- Fascia transversalis (1)
- FcγR (1)
- Femoral vein (1)
- Fibroblasts (1)
- Fluorouracil (1)
- Foxp3 (1)
- GDNF5 (1)
- GIST (1)
- GLP-1 (1)
- General anaesthesia (1)
- Groin infection (1)
- Growth-factor receptor (1)
- Göttingen (1)
- HBMEC (1)
- Heterotransplantation (1)
- Hickman catheter (1)
- High-fat diet (1)
- Hypertonic saline 7.5-percent (1)
- IL-6 (1)
- IVF-methods (1)
- Ileal conduit (1)
- Ileum-Conduit (1)
- Immunologie (1)
- Immunosenescence (1)
- Immunotherapy (1)
- Improved survival (1)
- In vitro models (1)
- Inhibition (1)
- Invasion (1)
- Inzisionale Hernie (1)
- Inzisionalhernie (1)
- KIT (1)
- Kono-S anastomosis (1)
- LAMN (1)
- LND (1)
- LNE (1)
- Lactated ringers solution (1)
- Laparoscopy (1)
- Leistenhernie (1)
- Leptin (1)
- Lernkurve (1)
- Linea alba (1)
- Low-fat diet (1)
- LyP (1)
- Lymph nodes (1)
- MAPK pathway (1)
- MAPK signaling cascades (1)
- MHC I (1)
- MHC Klasse II (1)
- MHC-Klass I (1)
- MITF (1)
- MIZ1 (1)
- MPFL (1)
- MRI (1)
- MTL30 (1)
- Major abdominal surgery (1)
- Makrophage (1)
- Mammalian target (1)
- Matrix (1)
- Melanom (1)
- Melanoma (1)
- Merkel cell carcinoma (1)
- Merkelzellkarzinom (1)
- Mesh Augmentation (1)
- Metastatic breast cancer (1)
- Mice (1)
- Minimalinvasiv (1)
- Minimalinvasive Leistenhernienversorgung (1)
- Minimally invasive surgery (1)
- Minischwein (1)
- Modifizierte Sugarbaker-Technik (1)
- Monoclonal antibody (1)
- Multicenter randomized-trial (1)
- NASH (1)
- NFATc1 (1)
- NPWT (1)
- Niere (1)
- Obturator bypass (1)
- Oncology (1)
- Organoids (1)
- Organtransplantation (1)
- P-glycoprotein (1)
- PCI (1)
- PCR (1)
- PDE (1)
- PDE4-I (1)
- PDGF (1)
- PET (1)
- PET imaging (1)
- PI-3-kinase (1)
- PI3K/Akt/mTOR (1)
- PLAG1 rearrangement (1)
- POEM (1)
- PYY3-36 (1)
- Parastomale Hernie (1)
- Pathway (1)
- Pauli procedure (1)
- Pauli-Verfahren (1)
- Pediatric malignancy (1)
- Peptidanaloge (1)
- Port (1)
- Posteriore Komponentenseparation (1)
- Postoperative complications (1)
- Predict fluid responsiveness (1)
- Primary hyperparathyroidism (pHPT) (1)
- Pulmonary function tests (1)
- Puls-pressure variation (1)
- RET6 (1)
- RNAPOL1 (1)
- RYGB (1)
- Radical prostatectomy (1)
- Radiochemotherapy (1)
- Randomized controlled-trial (1)
- Ratte (1)
- Regulatorischer T-Lymphozyt (1)
- Regulatory T cells (1)
- Retromuskuläres Netz (1)
- Retrorektus Netz (1)
- Robotik (1)
- Roux-en-Y gastric bypass (1)
- SSI (1)
- ST18 (1)
- Secondary traumatic brain damage (1)
- Serom (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- T cell receptors (1)
- T cells (1)
- TCR (1)
- TCR signaling cascade (1)
- TEER (1)
- TLR2 (1)
- TLR4 (1)
- TLR7 (1)
- TLR8 (1)
- TLR9 (1)
- TME (1)
- TNF (1)
- TNF receptor superfamily (1)
- TREC (1)
- Telomere (1)
- Thrombosis (1)
- Time interval (1)
- Tissue (1)
- Toll-like receptor signaling (1)
- Toll-like-Rezeptoren (1)
- Trichternetz (IPST) (1)
- Tumorerkrankungen (1)
- Umbilikalhernie (1)
- Up-regulation (1)
- V. saphena magna (1)
- VAC (1)
- VLBW (1)
- Ventrale Hernie (1)
- Y-gastric bypass (1)
- ZfKD (1)
- Zucker fatty fa/fa rats (1)
- [11C]-Choline PET/CT (1)
- [11C]-Methionine (1)
- [18F]FDG-PET-CT (1)
- [99mTc]-Sestamibi scan (1)
- abdominal compartment syndrome (1)
- abdominal lymph node metastases (1)
- abdominal surgery (1)
- abdominal trauma (1)
- abdominal wall hernia (1)
- abdominal wall surgery (1)
- accumulation (1)
- achalasia (1)
- acute (1)
- acute appendicitis (1)
- acute kidney injury (1)
- acute liver failure (1)
- acute respiratory distress syndrome (1)
- adipose-derived stromal/stem cells (ASCs) (1)
- adiposity (1)
- adjuvant (1)
- adrenal cancer (1)
- adrenal surgery (1)
- adrenal tumors (1)
- adrenalectomia (1)
- adrenocortical (1)
- adrenocortical adenocarcinoma (1)
- allograft rejection (1)
- allopeptide (1)
- alternative splicing (1)
- alveolar epithelium (1)
- anal atresia (1)
- anaplastic large cell lymphoma (1)
- anastomosis (1)
- anastomotic leak (1)
- anorectal abscess (1)
- anorectal angl (1)
- anorectal malformation (1)
- anti-tumor effects (1)
- antibiotic prescribing quality (1)
- antibiotic prescription behavior (1)
- antibiotic resistance (1)
- antibiotics (1)
- antithrombotic therapy (1)
- appendectomy (1)
- appendicitis (1)
- appendix (1)
- assisted reproductive techniques (1)
- autophagy (1)
- barrier models (1)
- benzoquinone (1)
- beta cells (1)
- biliopancreatic diversion (1)
- biological models (1)
- birth defects (1)
- bladder (1)
- blood (1)
- blood samples (1)
- blood-nerve barrier (1)
- blood–brain barrier (1)
- body fat (1)
- body mass index (BMI; kg/m\(^2\)) (1)
- body weight (1)
- bone marrow (1)
- brain metastases (1)
- brain plasticity (1)
- breast cancer (1)
- bronchopulmonary dysplasia (1)
- brown adipose tissue (1)
- bullae (1)
- burst abdomen (1)
- caco-2 cells (1)
- cadaver multiorgan preservation (1)
- caloric-restriction (1)
- cancer cells (1)
- cancer diagnosis (1)
- cancer risk (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- capture (1)
- carcinogenesis (1)
- carcinoma metastases to pancreas (1)
- carcinomas (1)
- cardiogenic (1)
- catheterization (1)
- catheters (1)
- cell cycle and cell division (1)
- cellular senescence (1)
- cerebEND (1)
- cerebral metastases (1)
- chemistry (1)
- chemokine receptor (1)
- children (1)
- children born (1)
- cholestasis (1)
- chylomicron (1)
- colloids (1)
- colon (1)
- colon carcinoma cells (1)
- colon resection (1)
- colorectal carcinoma (1)
- comet assay (1)
- complications (1)
- computed tomography angiography (CTA) (1)
- congenital malformations (1)
- continuous extracorporeal femoral perfusion model (1)
- conventional laparoscopic appendectomy (1)
- cord blood (1)
- cost-effectiveness (1)
- cotransporter SGLT1 (1)
- creatinine (1)
- curative resection (1)
- cytostatic (1)
- cytotoxicity (1)
- dass II antigen blockade (1)
- deconstruction into key steps (1)
- definition (1)
- dendritische Zellen (1)
- descriptive epidemiology (1)
- desmoglein (1)
- dexamethasone (1)
- diabetes (1)
- diagnosis (1)
- diagnostics (1)
- digital subtraction angiography (DSA) (1)
- discharge definition (1)
- drug-eluting beads (1)
- dual-room whole-body CT (1)
- duodenal jejunal bypass (1)
- duodenal perforation (1)
- duodenal trauma (1)
- elective surgery (1)
- endoscopic (1)
- endoscopic full thickness resection (eFTR) (1)
- endoscopic groin hernia repair (1)
- endosponge (1)
- endotoxemia (1)
- endovascular repair (1)
- energy homeostasis (1)
- enteric glial cells (1)
- enteric nervous system (1)
- enteroids (1)
- ephitelial cells (1)
- epidemiology (1)
- epidural block (1)
- epigastric hernia (1)
- epithelial cells (1)
- epithelium (1)
- erratum (1)
- esophageal perforation (1)
- expenditure (1)
- experimental models of disease (1)
- experimental therapy (1)
- extremity trauma (1)
- fascial closure (1)
- fat absorption (1)
- fat appetite (1)
- fatty liver (1)
- femoral arteries (1)
- femoral hernia (1)
- fish bone (1)
- fistulizing Crohn’s Disease (1)
- flow cytometry (1)
- focused surgical approach (1)
- folinic acid (1)
- food intake (1)
- foreign body ingestion (1)
- fracture-associated vascular damage (1)
- full-thickness resection device (FTRD) (1)
- funnel mesh (IPST) (1)
- gastric-bypass surgery (1)
- gastrointestinal cancer (1)
- gastrointestinal infections (1)
- gastrointestinal perforation (1)
- gastrointestinal tract (1)
- gemcitabine (1)
- gene regulation (1)
- generation (1)
- geriatric (1)
- germline mutation (1)
- glucagon like peptide-1 (1)
- glucocorticoid receptor (1)
- glucose homeostasis (1)
- glucose metabolism (1)
- glucose starvation (1)
- groin hernia (1)
- growth differentiation factor 15 (1)
- gut hormones (1)
- hematology (1)
- hemorrhagic (1)
- henoch-schönlein purpura (1)
- hepatic resection (1)
- hepatocellular carcinoma (1)
- hernia (1)
- hernia defect (1)
- hernia repair material (1)
- heterologous (1)
- histologic diversity (1)
- histopathology (1)
- human biomonitoring (1)
- human cancer (1)
- human melanoma (1)
- hypersensitivity (1)
- hypothalamic gene expression (1)
- hypoxia (1)
- idiopathic fecal incontinence (1)
- imaging (1)
- immaturity (1)
- immundominant (1)
- immune check inhibitor (1)
- immune response (1)
- immunity (1)
- immunodominant (1)
- immunosuppression (1)
- immunotherapeutics (1)
- impedance spectroscopy (1)
- imperforate anus (1)
- in vitro model (1)
- in vivo (1)
- in-vitro fertilization (1)
- incisional abdominal wall hernia (1)
- induced obesity (1)
- infants born (1)
- inflammation-induced tissue demage (1)
- inflammatory cell model (1)
- inguinal hernia (1)
- inguinal lymph node dissection (1)
- insulin resistance (1)
- intercellular junctions (1)
- intestinal barrier (1)
- intestinal glucose (1)
- intestinal microbiota (1)
- intestinal organoids (1)
- intestine (1)
- intraabdominal abscess (1)
- intragastric balloon (1)
- intravascular ultrasound (IVUS) (1)
- intravenous glucose tolerance test (1)
- ionizing radiation (1)
- irinotecan (1)
- islet transplantation (1)
- isocaloric intake (1)
- isosteviol sodium (STVNA) (1)
- kappa-B (1)
- ketogenic dients (1)
- ketogenic diet (1)
- ketone bodies (1)
- kidney (1)
- kidneys (1)
- la antigens (1)
- laparoscopic appendectomy (1)
- laparoscopic course (1)
- laparoscopic right colectomy (1)
- laparoscopic skills (1)
- laparoscopy (1)
- late onset sepsis (1)
- learning curve (1)
- left hemicolectomy (1)
- leptin (1)
- leptin system (1)
- leukemia (1)
- level of evidence: IV (1)
- linea alba (1)
- lipoblastoma (1)
- lipodystrophy (1)
- liver resection (1)
- locally advanced disease (1)
- low molecular heparin (1)
- low-grade mucinous neoplasm (1)
- low-molecular heparin (1)
- low-risk intra-abdominal infections (1)
- lung resection (1)
- lymph node dissection (1)
- lymph nodes (1)
- lymphadenectomy (1)
- lymphomatoid papulosis (1)
- magnetic resonance imaging (1)
- maintain immune homeostasis (1)
- management (1)
- mass (1)
- mastocytosis (1)
- measles virus (1)
- medial patellofemoral ligament (1)
- meningitis (1)
- mesenchymal stem cells (1)
- mesh augmentation (1)
- mesh repair (1)
- metaanalysis (1)
- metabolic profile (1)
- metabolically unhealthy obesity (1)
- metachronous (1)
- miRNA expression (1)
- mice (1)
- microbiota (1)
- mild hypothermia (1)
- minimally invasive (1)
- modified Sugarbaker technique (1)
- mold exposure (1)
- molecular diagnostics (1)
- monocyte subsets (1)
- monocytes (1)
- mortality rate (1)
- mucormycosis (1)
- mucosal healing (MH) (1)
- multimodal (1)
- myeloid (1)
- nab-paclitaxel (1)
- negative pressure wound therapy (1)
- neoadjuvant (1)
- neoadjuvant chemotherapy (1)
- neonatal immunology (1)
- neonatal meningitis (1)
- neonatal outcome (1)
- netrin-1 (1)
- neuroblastoma – diagnosis (1)
- neuroendocrine tumor (NET) (1)
- neuroinflammation (1)
- neuropathic pain (1)
- neurotrophic factors (1)
- noradrenaline (1)
- noradrenaline transporter (1)
- novel human cadaveric perfusion model (1)
- obesity surgery (1)
- octogenarians (1)
- octogenerians (1)
- older adult (1)
- oncogene-induced senescence (1)
- open appendectomy (1)
- open wound treatment (1)
- operative (1)
- oral anticoagulants (1)
- organoid (1)
- outcome (1)
- pancreas Islets (1)
- pancreatectomy (1)
- pancreatic adenocarcinoma (PDAC) (1)
- pancreatic head cancer (1)
- parathyroid adenoma (1)
- parathyroid carcinoma (1)
- patella alta (1)
- patella dislocation (1)
- patella instability (1)
- pathway analysis (1)
- patient-derived organoid (PDOs) (1)
- patient-derived tumor organoid (PDTO) (1)
- pediatric adrenocortical adenoma (1)
- pediatric adrenocortical cancer (1)
- pediatric adrenocortical tumor (1)
- pelvic trauma (1)
- pembrolizumab (1)
- pemphigus (1)
- penetrating ileitis (1)
- peptide analogs (1)
- peptide tyrosine tyrosine 3-36 (PYY3-36) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- perianal fistulas (1)
- perioperative antibiotic prophylaxis (1)
- perioperative chemotherapy (1)
- periphery-brain interactions (1)
- peritonitis (1)
- permeability (1)
- peroral endoscopic myotomy (1)
- phosphodiesterase-4 (1)
- phosphodiesterase-inhibitors (1)
- photon-counting computed tomography (CT) (1)
- pig or swine (1)
- platelet dysfunction (1)
- popliteal aneurysm (1)
- positron emission tomography imaging (1)
- post-mortem heart recovery (1)
- post-operative antibiotic treatment (1)
- posterior component separation (1)
- postoperative inflammation (1)
- preclinical research (1)
- preoperative localization (1)
- preterm birth (1)
- prevalence (1)
- primary hyperparathyroidism (1)
- primär ventrale Hernie (1)
- prognosis (1)
- prognostic factors (1)
- prospective studies (1)
- protein expression (1)
- protein kinase D2/PKD2/PRKD2 (1)
- protein synthesis (1)
- quality of life (1)
- radiotracer (1)
- reactivating p53 and inducing tumor apoptosis (RITA) (1)
- reactive oxygen (1)
- reactive oxygen species (1)
- real-time glucose monitoring (1)
- rectal cancer (1)
- rectal resection (1)
- recurrence survival (1)
- recurrent abdominal wall hernia (1)
- regeneration (1)
- regenerative medicine (1)
- regional recurrence (1)
- regionalization and organoids (1)
- registries (1)
- regulatory T cells (1)
- renal transplantation (1)
- repeat surgery (1)
- repeated surgery (1)
- reproductive medicine (1)
- resuscitation time (1)
- retromuscular mesh (1)
- retroperitoneal tumor (1)
- retrorectus mesh (1)
- retrospective study (1)
- reverse transcriptase-polymerase chain reaction (1)
- review (1)
- ribosome (1)
- risk factor (1)
- risk factors (1)
- robotic surgery (1)
- robotic surgical procedures (1)
- rolipram (1)
- rygb (1)
- sacral nerve stimulation (1)
- sacral neuromodulation (1)
- screening (1)
- seahorse (1)
- secondary skin closure (1)
- secretion (1)
- seminoma (1)
- septic (1)
- seroma (1)
- serotonin (1)
- serotonin transporter (1)
- shock (1)
- single-port appendectomy (1)
- sleeve gastrectomy (1)
- small bowel (1)
- small interferring RNA (1)
- small pixel effect (1)
- streptozotocin (1)
- super-obesity (1)
- superior (1)
- surgical (1)
- surgical and invasive medical procedures (1)
- surgical care (1)
- surgical complications (1)
- surgical intra-abdominal infections (1)
- surgical management (1)
- surgical oncology (1)
- surgical outcome (1)
- surgical procedures (1)
- surgical resection (1)
- surgical site infection (1)
- surgical site infections (1)
- surgical trauma room (1)
- surgical treatment (1)
- survival (1)
- survival analysis (1)
- sympathetic nervous system (1)
- systematic review (1)
- systemic and cutaneous CD30+ lymphoproliferations (1)
- systemic endotoxemia (1)
- teaching methods (1)
- technology (1)
- terminal ileitis (1)
- thermogenesis (1)
- thyroid gland (1)
- thyroiditis (1)
- tight junction (1)
- tight junction proteins (1)
- tissue (1)
- tolerance (1)
- total pancreatectomy (1)
- transanal endoscopic microsurgery (TEM) (1)
- transarterial chemoembolization (1)
- translation (1)
- translation initiation (1)
- transplant (1)
- transstomal endoluminal vacuum therapy (1)
- transverse fascia (1)
- trauma centre (1)
- trauma management (1)
- trochlear dysplasia (1)
- trophic factors (1)
- tumor disease (1)
- tumor growth (1)
- type 2 diabetes (1)
- ultrahigh resolution (1)
- uncoupling protein 1 (1)
- urinary tract infections (1)
- urine (1)
- vascular type (1)
- vasculitis (1)
- ventral hernia model (1)
- visceral fat (1)
- vitamin D (1)
- volume (1)
- warfarin interruption (1)
- weight-gain (1)
- wound infection (1)
- xenogeneic transplantation (1)
- xenogenic transplantation (1)
- β-Hydroxybutyrate (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (232) (remove)
Sonstige beteiligte Institutionen
The GVHRIL foHowing transplantation of small intestine are different from those found after bone marrow transplantation or spleen cell injections in that they show a remarka ble, significant prevalence of lesions within the intestinal mucosa. These findings are consistent with the observation that jntestinal lymphocytes newly formed in mesenteric lymph nodes predominantly home in on the intestine again.& The degree of histologic alteration within different tissues indicates that the graft and the host may survive the lesions of the lymphatic tissues, whereas the severe intestinal lesions following GVHR may easily cause death of the recipient. With regard to clinical sman bowel transplantation two statements can be made: (l) GVHRIL play a significant role in small bowel trans~ plantation. (2) To minimize their biologic importance, a selective elimination of the graft's Jymph nodes by irradiation or surgical resection should be considered in view of the remarkable difference between GVHRIL in lymph nodes and in the graft's intestinal wall itself.
In the present study, an attempt was made to characterize the immunomodulating abilities of the cytostatic drugs cydophosphamide, ifosfamide, vinblastine, vincristine, procarbazine, dacarbazine, 6-mercaptopurine, methotrexate, 5-f/uor-uracil and adriamycine in a defined experimental model. Varying combinations of drug plus transplantation alloantigen, (C3H-lymphocytes) were injected into Balb/c mice at different time intervals in vivo. The resulting T-effector cell reactivity was determined in vitro with the microcytotoxicity assay on day + 5 for primary (r) and day + 7 for secondary (2°) sensitized mice. According to the type of drug (alkylating agent vs. vinca alkaloid vs. antimetabolite vs. cytostatic antibiotic), the dosage (20% LD50 vs. 60% LD50), the state of sensitization (r vs. 2° sensitized recipients), and the time of drug application in relation to the antigen treatment on day 0 (in varying steps from day -6 to day +4), so-called "pharmaconantigen- variation-effects" (PA VE) were established for each of the investigated drugs in form of reaction profiles. The results were as folIows: (1) For almost alt substances, characteristic reaction profiles involving immunostimulation and/or immunosuppression could be established. Similarities in the profiles of different substances made it possible to classify the drugs according to different reaction types. The reaction type however is not definitely correlated to the biochemical mechanism of drug action. (2) The PA VE are decisively inf/uenced by so me of the biological parameters, such as the time of drug application in relation to the antigen treatment and the state of sensitization but relatively !ittle by the dosage of the drug. (3) Considering the different processes occurring du ring primary and secondary immune responses, the PAVE may give hints for a distinct manipulation of the immunoregulation and thus information on the immunobiological mechanism of drug action.
It is the aim of this study to characterize and quantify the cells within isolated rat islets that express MHC class 11 antigens. A set of five monoelonal antibodies and two polyclonal antisera of defined specificlty were used in combination with a newly devised procedure for three·dimensional immunofluorescence evaluation of intact islets. It is shown that in addition to passen· ger cells, such as Iymphocytes, macro· phages, and dendrlticlike cells, vascular endothelial and endocrine cells are also capable of expressing class 11 antigens. This expression Is strongly influenced by in vitro culture. pregnancy, streptozotocin- induced diabetes, transplantation trauma, and alloantigenic stimuli. The pos· sible role of the above cells in antigen presentation related to islet transplantation is discussed.
Total immunoreactive insulin (IRI) is conventionally determined by radioimmunoassays. IR! measurement in rats can be made more sensitive, accurate, and practical, as demonstrated by a new modified enzyme-linked immunosorbent assay (ELlSA). It is characterized by indirect binding of an anti-insulin antibody by an antiglobulin antibody and uses the principle of competitive saturation. In this ELlSA, IRI can be determined in a wide range of concentrations, corresponding to the standards. The standard curve ranges from 100 to 0.049 ng/mllRI (1 ng/ml - 23.4 JLU/ml - 172 pM rat insulin). The statistical analysis shows between- and within-assay coefficients of variation of :515%. Diabetes 37:321-26,1988
An immunogold-silver enhancement technique, which combines effective labeling of viable isolated islets with the ultrastructural resolution of cytological details, was applied in electron microscopy to identify major histocompatibility complex (MHC) structures on islet cells. Incubation of freshly isolated islets from CAP (RT1C) and LEW (RT1') rats with OX18, an MHC class I antibody, showed strong positive reactivity in macrophages and/or dendritic-like cells (M0-DCs) and vascular endothelial cells (VEs) and a comparatively weaker reactivity in endocrine a-, p-, and 8-ce"s. With MHC class" antibody OX6 (anti-I-A), M0-DCs were strongly labeled in both rat strains on the surface and on internal structures. Three of five particularly high titered batches of OX6 revealed MHC class" expression on VE and p-ce"s. Four days of in vitro culture in combination with a high concentration of glucose and interferon-'Y induced strong enhancement of MHC class I structures and, to a lesser extent, class " structures on p-ce"s.
Because successful human islet transplantation requires large quantities of viable islets that must be separated from the highly immunogenic exocrine tissue and because handpicking is too time-consuming and laborious to be clinically relevant, a new approach for solving this problem has been established in rat models. It is based on the principle that magnetic microspheres (MMSs) coupled to lectins with binding specificity for the exocrine tissue portion are trapped in an electromagnetic field, thus providing effluent islets of a high degree of purity. In this study our aim was to adapt this princip'le to human islet preparations. In this context our prime interest was focused on a lectin suitable for human pancreatic tissue. Of 19 different lectins tested, only 1, Wisteria floribunda agglutinin (WFA), is suitable, as shown by immunofluorescence, MMS-Iectin binding, and magnetic separation
To decrease immunogenicity of the rat kidney, grafts were perfused with an anti-MHC class li monoclonal antibody (mAb ). How effectively this procedure blocked dass li-positive cells, which were mainly dendritic in appearance, was checked by immunostaining renal sections after perfusion and comparing them with in vitro stained sections. Optimum conditions were applied for graft pretreatment before transplantation. This procedure prolonged graft survival, though not satisfactorily from the biological point ofview (9.6 ± 0.8 versus 7.7 ± 0.5 days in the control group; P < 0.02). The dendritic cells were not killed but blocked. Several hours after transplantation, the mAb dissociated from these dass li-positive cells. It was also shown that donor cells migrate into the recipient's spieen early after transplantation. The number of these cells was smaller when the transplanted organ was perfused with the mAb. Further studies are suggested to deplete the graft of donor dendritic cells more adequately. They should also combine graft perfusion with antidass II mAb and recipient immunosuppression at reduced doses.
No abstract available.
Since systematic hematological studies on blood and bone marrow changes after treatment with 15-Deoxyspergualin (DOS) are lacking, a quantitative assessment was performed fourteen or twenty eight days after intraperitoneal application of DOS to rats. Further observations done 7 and 14 days after discontinuation of DOS administration allowed analysis of banc marrow regeneration. DOS induced lymphocytopenia, granUlocytopenia and anemia with a decrease of bone marrow cellularity due to suppression of cell maturation. The effect was dose-dependent and bone marrow as well as blood changes were observed in animals treated with doses from 0.5 to 10.0 mg/kg DOS. Within 14 days after termination of the treatment, rapid recovery with normalization of all hematological parameters was observed. In the light of our data, these hematological side effects may not be a major disadvantage, if DOS is used in doses below 2.5 mg/kg, and for a course of therapy which is limited to 7 to 14 days.